Investment Rating - The report assigns a "Buy-B" rating for the company, indicating a positive outlook for its stock performance in the coming months [6]. Core Insights - The company's performance is closely linked to the palm oil market, which has shown signs of recovery. The increase in palm oil prices has positively impacted the company's product pricing and gross margins [6][4]. - The company reported a significant improvement in its financials for Q3 2025, with a revenue increase of 6.22% year-on-year and a net profit increase of 83.15% year-on-year, primarily driven by the recovery in palm oil prices [4][5]. - The Indonesian government's B50 biodiesel policy is expected to create a long-term upward trend in palm oil prices, which will benefit the company [5][6]. Financial Performance Summary - For the first three quarters of 2025, the company achieved a revenue of 9.676 billion yuan, a year-on-year increase of 27.92%, and a net profit of 151 million yuan, up 24.96% year-on-year [4]. - The gross margin for Q3 2025 was reported at 6.95%, with a net margin of 1.59%, indicating a recovery in profitability [5]. - The forecast for net profit from 2025 to 2027 is projected to be 210 million yuan, 430 million yuan, and 570 million yuan, respectively, with corresponding P/E ratios of 25, 12, and 9 [6][9].